In this issue briefing, the authors examine the direct and indirect costs of cardiovascular disease and their impact on the public health care system and economy of Brazil, from 2016 to 2035.
Modelling the Burden of Cardiovascular Disease in Brazil
Modelling the Burden of Cardiovascular Disease in Brazil
Health and Healthcare
$0.00
CVD is the leading cause of death globally. Between 2016 and 2035, the number of Brazilian adults with CVD will double, going from 6.2 million to 13.6 million. Meanwhile, the costs of health care and lost productivity will triple, going from US$13.7 billion in 2016 to US$40 billion by 2035. Direct costs are expected to increase at a faster rate than indirect costs, reaching US$26 billion and US$14 billion, respectively, by 2035. Without additional measures to mitigate the impact of population aging and modifiable risk factors, the burden of CVD in Brazil will only continue to grow.
In Modelling the Burden of Cardiovascular Disease in Brazil, the economic burden of cardiovascular disease (CVD) is approached from two perspectives—the direct costs of delivering health care services and their impact on the public health care system, and the indirect costs from productivity losses, which impact the broader society and economy.
Customers Who Downloaded This Also Liked
Require an accessible version of this research?
Upon request, Signal49 Research offers accessible versions of research. Please contact us to request your accessible version.
Learn more about our accessibility policies.
Effective January 26, 2026, AERIC Inc./Signal49 Research discontinued use of ‘The Conference Board of Canada’ name, logo and branding, which had been used by AERIC Inc./Signal49 Research under license from The Conference Board, Inc. The Conference Board, Inc. and its licensees, which are not affiliated with Signal49 Research, own all right, title and interest in THE CONFERENCE BOARD name and trademarks in Canada and have the exclusive right to their use in Canada since January 26, 2026.
